Skip to main content
HROW logo

HROW · Harrow, Inc. · Executive Compensation

Track HROW — free
$31.47 -0.66 (-2.05%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.21B
Shares
37.53M
Volume · Nov 19 762.87K Avg daily vol (3M) 617.04K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Mark L. Baum $23,606,274
Andrew R. Boll $10,947,441
Amir Shojaei $1,342,627
Francis W. Mullery $1,237,692
John P. Saharek $727,421
Fiscal 2024
Executive Total
Mark L. Baum $1,358,490
Andrew R. Boll $849,201
John P. Saharek $743,467
Fiscal 2023
Executive Total
Mark L. Baum $15,256,463
Andrew R. Boll $7,130,409
John P. Saharek $5,815,154
Fiscal 2022
Executive Total
Mark L. Baum $1,195,141
Andrew R. Boll $764,386
John P. Saharek $656,887
Fiscal 2021
Executive Total
Mark L. Baum $7,321,467
Andrew R. Boll $3,352,154
John P. Saharek $2,676,858
Fiscal 2020
Executive Total
Mark L. Baum $2,483,296
Andrew R. Boll $1,016,804
John P. Saharek $533,538
Fiscal 2019
Executive Total
Mark L. Baum $1,377,012
Andrew R. Boll $1,049,545
John P. Saharek $963,798

Executive changes

Person Change Filed
Randall E. Pollard Terminated 2026-09-04
Patrick W. Sullivan Appointed 2026-02-02
Frank Mullery Appointed 2025-10-06
Bridseida Cruz Appointed 2025-10-06
Randall E. Pollard Appointed 2025-08-25
Andrew R. Boll Appointed 2025-08-25
Marty A. Makary
“Dr. Makary did not resign as a result of any disagreements with the Company on any matter relating to the Company's operations, policies or practices.”
Resigned 2025-01-21
Lauren P. Silvernail Appointed 2024-01-29
Adrienne L. Graves Appointed 2024-01-29
John P. Saharek Appointed 2024-01-03
Perry J. Sternberg Appointed 2023-11-03
Martin A. Makary Appointed 2023-11-03
R. Lawrence Van Horn
“Mr. Van Horn did not resign as a result of any disagreements with the Company on any matter relating to the Company's operations, policies or practices.”
Resigned 2023-11-03
Robert J. Kammer
“Dr. Kammer did not resign as a result of any disagreements with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2022-03-31

Leadership

Key facts CIK 1360214 CUSIP 415858109 13F (30d) 212 filings 189 filers Visit website Investor relations